We now have the recently released July 2019 Medicare Part D prescription drug plan formulary (drug lists) data online and included in our Formulary Browser and Drug Finder. The July formulary updates include the addition of 57 new National Drug Codes (NDCs), representing 33 different prescription drugs, many with multiple strengths. The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the July 2019 formulary updates include three newly-added generic drugs: The July Medicare Part D drug data includes fourteen generic medications, with three (3) being newly-introduced generic drugs. These drugs include:
- AMBRISENTAN [LETAIRIS®],
- DEFERASIROX [Exjade®], and
- SOLIFENACIN [VESIcare®].
You can see our article "July 2019 Drug List Updates: Fourteen (14) new generic drugs added to many Medicare Part D plan formularies" found at on this site for more about coverage for all of the new generics.
The July 2019 Formulary Update Includes Six Newly-Added Brand-Name Drugs: The July drug data also updates includes the introduction of six (6) newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- BALVERSA®,
- EVENITY®,
- FULPHILA®,
- QMIIZ®,
- ROCKLATAN®, and
- SKYRIZI®.
Reminders about Medicare prescription drug plan formulary changes
(1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
(2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.
Reminder: What is the NDC?
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 57 new NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Drug | 16 |
| New Drug and Strength | 25 |
| New Manufacturer | 2 |
| New Manufacturer and Strength | 5 |
| New Strength | 9 |
| Total New NDCs | 57 |
The following chart details the 57 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Code (NDC) or Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 00023614501 | ACTIGALL 300 MG CAPSULE | 2 | 8 | New Drug |
| 00093317431 | ALBUTEROL HFA 90 MCG INHALER HFA AER AD [Ventolin HFA] | 18 | 189 | New Manufacturer |
| 00254100752 | ALBUTEROL HFA 90 MCG INHALER HFA AER AD [Ventolin HFA] | 4 | 90 | New Manufacturer |
| 70710118003 | AMBRISENTAN 10 MG TABLET [LETAIRIS] | 58 | 336 | New Drug and Strength |
| 70710117903 | AMBRISENTAN 5 MG TABLET [LETAIRIS] | 58 | 336 | New Drug and Strength |
| 00781578931 | AZITHROMYCIN 500 MG TABLET [Zithromax Tri-Pak] | 62 | 354 | New Drug |
| 59676003084 | BALVERSA 3 MG TABLET | 45 | 315 | New Drug and Strength |
| 59676004056 | BALVERSA 4 MG TABLET | 45 | 315 | New Drug and Strength |
| 59676005028 | BALVERSA 5 MG TABLET | 45 | 315 | New Drug and Strength |
| 50383024971 | BROMFENAC SODIUM 0.09% EYE DROPS [Xibrom] | 23 | 246 | New Drug |
| 45963045430 | DEFERASIROX 125 MG TABLET DISPER [Exjade] | 35 | 254 | New Drug and Strength |
| 45963045530 | DEFERASIROX 250 MG TABLET DISPER [Exjade] | 35 | 254 | New Drug and Strength |
| 45963045630 | DEFERASIROX 500 MG TABLET DISPER [Exjade] | 35 | 254 | New Drug and Strength |
| 50458010605 | DURAGESIC 100 MCG/HR PATCH TD72 | 0 | 4 | New Strength |
| 50458010105 | DURAGESIC 12 MCG/HR PATCH TD72 | 0 | 4 | New Strength |
| 50458010405 | DURAGESIC 50 MCG/HR PATCH TD72 | 0 | 4 | New Strength |
| 50458010505 | DURAGESIC 75 MCG/HR PATCH TD72 | 0 | 4 | New Strength |
| 52856050203 | EMFLAZA 18 MG TABLET | 3 | 86 | New Manufacturer and Strength |
| 52856050303 | EMFLAZA 30 MG TABLET | 3 | 86 | New Manufacturer and Strength |
| 52856050403 | EMFLAZA 36 MG TABLET | 3 | 86 | New Manufacturer and Strength |
| 52856050101 | EMFLAZA 6 MG TABLET | 3 | 86 | New Manufacturer and Strength |
| 00378807593 | ERYGEL 2% GEL | 3 | 16 | New Drug |
| 62559063101 | ERYTHROMYCIN 400 MG/5 ML SUSP Oral Suspension [EryPed] | 23 | 191 | New Strength |
| 55513088002 | EVENITY 210 MG DOSE-2 SYRINGES | 2 | 56 | New Drug |
| 67877049030 | EZETIMIBE 10 MG TABLET [Zetia] | 62 | 354 | New Drug |
| 62332024490 | FENOFIBRIC ACID DR 45 MG CAPSULE DR [Trilipix] | 30 | 229 | New Manufacturer and Strength |
| 69292072225 | FLURBIPROFEN 0.03% EYE DROPS [Ocufen] | 60 | 351 | New Drug |
| 00093744601 | FLUVASTATIN ER 80 MG TABLET ER 24H [Lescol XL] | 11 | 159 | New Drug |
| 67457083306 | FULPHILA 6 MG/0.6 ML SYRINGE | 7 | 151 | New Drug |
| 59148008213 | JYNARQUE 15 MG TABLET | 6 | 133 | New Strength |
| 59148008313 | JYNARQUE 30 MG TABLET | 6 | 133 | New Strength |
| 00023601360 | KADIAN ER 30 MG CAPSULE ER PEL | 0 | 5 | New Strength |
| 00115994108 | LAMOTRIGINE ODT 100 MG TABLET RAPDIS [Lamictal ODT] | 14 | 203 | New Drug and Strength |
| 00115994208 | LAMOTRIGINE ODT 200 MG TABLET RAPDIS [Lamictal ODT] | 14 | 202 | New Drug and Strength |
| 00115994008 | LAMOTRIGINE ODT 50 MG TABLET RAPDIS [Lamictal ODT] | 14 | 198 | New Drug and Strength |
| 69238161006 | LOPREEZA 1 MG-0.5 MG TABLET [Mimvey ] | 21 | 124 | New Drug |
| 76385012901 | METFORMIN HCL ER 750 MG TABLET ER 24H [Glucophage XR] | 62 | 354 | New Drug |
| 16714070701 | MIRTAZAPINE 15 MG TABLET [Remeron] | 62 | 354 | New Drug and Strength |
| 16714070801 | MIRTAZAPINE 30 MG TABLET [Remeron] | 62 | 354 | New Drug and Strength |
| 65597030410 | MORPHABOND ER 100 MG TABLET ER 12H | 0 | 12 | New Drug and Strength |
| 65597030110 | MORPHABOND ER 15 MG TABLET ER 12H | 0 | 12 | New Drug and Strength |
| 65597030210 | MORPHABOND ER 30 MG TABLET ER 12H | 0 | 12 | New Drug and Strength |
| 65597030310 | MORPHABOND ER 60 MG TABLET ER 12H | 0 | 12 | New Drug and Strength |
| 13668025230 | OLMESARTAN-HCTZ 40-12.5 MG TABLET [Benicar HCT] | 56 | 321 | New Drug |
| 00603533832 | PREDNISONE 10 MG TABLET [Sterapred DS] | 62 | 354 | New Drug |
| 70720011599 | QMIIZ ODT 15 MG TABLET RAPDIS | 0 | 2 | New Drug and Strength |
| 70720017599 | QMIIZ ODT 7.5 MG TABLET RAPDIS | 0 | 2 | New Drug and Strength |
| 52817016160 | QUETIAPINE ER 150 MG TABLET ER 24H [Seroquel XR] | 49 | 297 | New Drug and Strength |
| 52817016260 | QUETIAPINE ER 200 MG TABLET ER 24H [Seroquel XR] | 49 | 297 | New Drug and Strength |
| 33342013609 | QUETIAPINE ER 300 MG TABLET ER 24H [Seroquel XR] | 49 | 297 | New Drug and Strength |
| 52817016060 | QUETIAPINE ER 50 MG TABLET ER 24H [Seroquel XR] | 49 | 297 | New Drug and Strength |
| 70727052925 | ROCKLATAN 0.02%-0.005% EYE DROPS | 0 | 10 | New Drug |
| 68462044626 | SEVELAMER HCL 400 MG TABLET [RenaGel] | 8 | 135 | New Strength |
| 00074204202 | SKYRIZI 150 MG DOSE KIT-2 SYRINGEKIT | 10 | 104 | New Drug |
| 00093526456 | SOLIFENACIN 10 MG TABLET [VESIcare] | 31 | 205 | New Drug and Strength |
| 00093526356 | SOLIFENACIN 5 MG TABLET [VESIcare] | 31 | 205 | New Drug and Strength |
| 69097052603 | TADALAFIL 20 MG TABLET [ALYQ] | 35 | 232 | New Drug |
*The number of formularies counts the unique formularies that offer this medication. As a note, the same formulary can be used by one or many different Medicare Part D plans. The same formulary can be used by both PDP and MAPD plans.
Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the on this site FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.